UCLPartners

UCLPartners

Hospitals and Health Care

We are a health innovation partnership. Our mission is to help five million people from North London to the Essex coast.

About us

We are a health innovation partnership. Our mission is to help five million people from North London to the Essex coast live longer, healthier lives. We focus on the health challenges that have the biggest impact on the people most in need. Our work aims to prevent people from becoming ill, give them quicker access to care and transform the quality of their treatment.

Industry
Hospitals and Health Care
Company size
51-200 employees
Headquarters
London
Type
Partnership
Founded
2009
Specialties
AHSN, AHSC, NIHR CLAHRC, Education Lead Provider, NIHR CRN, Health, Innovation, Quality and Value, Research, Informatics, Wealth creation, Education, Cancer, Mental Health, Cardiovascular disease, Children, young people and maternal health, and Co-morbidities

Locations

Employees at UCLPartners

Updates

  • View organization page for UCLPartners, graphic

    6,770 followers

    It is great to see our evaluation work for Digital Health Passport being shared by Kate Cheema in this podcast. Find out more about how this innovation is improving asthma management in their podcast episode 👇

    🎙 In this episode of the Up Up and Away podcast, host Dom Burch welcomes Kate Cheema, Director of Evaluation and Insight at UCLPartners. With over 17 years in NHS data analysis and patient safety, Kate offers a deep dive into the transformative power of data and AI in healthcare, describing her work as “turning all this nerdy gold into something meaningful for people working directly with patients”. 📊 Kate describes her passion for data analysis, embracing her role in transforming vast datasets into valuable insights that directly support healthcare professionals. Rather than simply accumulating data, her team’s mission is to make this information actionable, providing clarity and direction to those in patient-facing roles. 💰 Focusing on asthma management, she highlights the substantial financial burden of uncontrolled asthma, emphasising that solutions like the Digital Health Passport (DHP) not only improve patient outcomes but also offer significant cost savings by helping patients better manage their conditions. 📈 The DHP’s tracking feature, highly valued by users, fosters a sense of empowerment and control, transforming routine health data into a daily tool for self-management. 🚨 By targeting young people and underserved communities, Kate reveals the DHP for asthma has demonstrated a 2.24-point improvement in asthma control, which she notes is both statistically significant and practically impactful. She emphasises the empowering nature of the DHP, saying, “Knowledge is power, and having that in the palm of your hand gives a sense of control”. 🤖 Kate also discusses the broader potential of AI in healthcare, describing it as an “exciting time to be alive” as unstructured data becomes actionable through advanced text analysis tools, making patient voices central to healthcare improvements. Her team, she explains, acts as a “translator,” bridging data insights with real-world applications, from clinical settings to patient self-management. 💷 The Digital Health Passport’s role in reducing emergency visits and improving asthma self-management also promises a significant cost-saving, with an ROI of £9.28 for every £1 spent, illustrating the financial and healthcare benefits of data-informed innovation. As Kate puts it, “Uncontrolled asthma is really expensive… Anything that helps people move into a more controlled space will save potentially very significant sums of money”. 🚑 Kate’s podcast offers insights for healthcare innovators and underscores the profound impact of data on patient well-being, affirming the role of tools like the DHP in improving health outcomes and accessibility. ➡ Listen here: https://lnkd.in/egGhQRzk Greg Burch, Matt Bourne, Paul S Weston, Saira S. Arif 🍉, Jo Grim, Marta Denkiewicz, Monica Fletcher OBE, Naomi Watt, Laura King

    • a smiling portrait of Kate Cheema
  • View organization page for UCLPartners, graphic

    6,770 followers

    Today is World Stroke Day – a time to reflect on the importance of stroke prevention and care for the communities we serve. We're committed to supporting our health systems, enabling them to transform stroke prevention and tackle health inequalities. In North East London primary healthcare providers are identifying individuals at risk, offering targeted support, and helping prevent strokes before they happen. This work is about creating real, lasting change for people who need it most. Read more about the work of Sotiris Antoniou and his colleagues here: https://lnkd.in/eBYFquWK #WorldStrokeDay #StrokePrevention #HealthInnovation #PrimaryCare #StrokeAwareness #HealthEquity

    Transforming stroke prevention in North East London - UCLPartners

    Transforming stroke prevention in North East London - UCLPartners

    uclpartners.com

  • View organization page for UCLPartners, graphic

    6,770 followers

    Making meaningful impact! Last year our CVD Academy ambassadors reached and supported hundreds of people with their projects focused on cardiovascular disease prevention. Throughout the programme we shared with them the skills, knowledge and networks to enable them to implement projects in their area to solve some of the biggest challenges in cardiovascular disease. Inspired by their impacts? If you too are a GP, pharmacist or nurse with a passion for prevention and solving health inequalities in cardiovascular disease you can apply for our next cohort now: https://lnkd.in/eMFBwaUE #CardiovascularDisease #HealthInnovation #CVDPrevention

  • UCLPartners reposted this

    View profile for Arup Nath, PhD, graphic

    Commercial Director | Innovation in Health and Medicines | UCLPartners

    Today, the MHRA has licensed donanemab for early stages of Alzheimer's disease - however NICE has not approved it for use in the NHS. This is disappointing news, as was the similar announcement with lecanemab earlier this year. But we know there are many other disease modifying treatments in the pipeline and we need to be ready to deliver treatments like this across our healthcare systems.   Which is why it's so important for organisations like ours to continue to innovate in dementia care. By bridging the gap between academia, industry, healthcare and the third sector, we are accelerating meaningful progress in dementia care, ensuring better outcomes for those affected, both locally and beyond.   Our work is focused on improving the lives of patients with dementia, reducing the pressure on their families and the healthcare system, and reducing existing health inequalities.   If you are interested in working with us, please DM me or reach me at: arup.nath@uclpartners.com UCLPartners John Craig Chris Laing Rebecca Shipley Jessica Thomas Valentina Karas Ilias Zapantis Luís Tojo Libby Graham Ellen McIntosh Katie Harrison

    NICE does not recommend Donanemab for mild cognitive impairment or dementia caused by Alzheimer's disease. The costs associated with this treatment, coupled with the need for intensive monitoring to address potential severe side effects, outweigh the limited benefits it offers to patients. As a result, it cannot be considered good value for the taxpayer. Further information: https://lnkd.in/ekt6hErA

    • Graphic showing photo of healthcare professional looking at brain scans and the following text: New Alzheimer's treatment donanemab does not currently demonstrate value for the NHS.
  • View organization page for UCLPartners, graphic

    6,770 followers

    Are you a primary healthcare professional? Do you want to transform cardiovascular care? Join our webinar to learn about our CVD Academy — a 12-month programme for GPs, pharmacists, and nurses to lead local cardiovascular disease projects, gain expert knowledge, and connect with peers. 📅 Register now to learn more: https://lnkd.in/e6BV_xRH

    • No alternative text description for this image
  • UCLPartners reposted this

    View profile for Natt Day, graphic

    Head of Patient and Public Involvement and Engagement at UCLPartners

    This morning Rachana Bhatt, Jagjot Kaur Chahal, Sotiris Antoniou and I were out and about in Plaistow, speaking to local residents about cholesterol point of care testing in their community pharmacy. It was great to get resident feedback on the current plans and hear their suggestions about how we can make the service even more accessible and supportive for those in the neighbourhood. 👀 Stay tuned to UCLPartners for more information about the Point of Care Testing pilot programme in North East London... coming very soon!

    • No alternative text description for this image
  • View organization page for UCLPartners, graphic

    6,770 followers

    "It's their enthusiasm to just do better. Fantastic to see the multidisciplinary cohort of doctors, nurses and pharmacists as part of the CVD academy bringing to life their commitment to delivering for their patients and practice populations."     Applications for our next CVD Academy are currently open.     If you're a GP, pharmacist, or nurse passionate about preventing cardiovascular disease in North Central London, North East London or Mid and South Essex - this opportunity is for you!   The Academy will provide you with the knowledge, skills and networks to lead innovations that help to prevent heart attacks and strokes.   Thank you Helen Williams for sharing your views!   #CVDPrevention #HealthcareLeadership #CardiovascularHealth #HealthInnovation #TacklingInequality #HealthcareCommunity   Aiysha Saleemi Mike Osaer Harry Albert Rachana Bhatt Matt Kearney Apply now: https://lnkd.in/eMFBwaUE

  • View organization page for UCLPartners, graphic

    6,770 followers

    Did you know that cardiovascular disease (CVD) accounts for 20% of the life expectancy gap between the most affluent and most deprived communities? We’re on a mission to tackle this and lead change in CVD prevention. Our CVD Academy is now in its second year and we’re looking for motivated healthcare professionals from North Central London, North East London, and Mid & South Essex to join the programme and become CVD prevention champions. In return we will provide the knowledge, skills, and networks that primary care professionals need to lead and implement innovations that will reduce heart attacks, strokes, and other forms of CVD. Find out more and apply on our website: https://lnkd.in/eMFBwaUE

    • No alternative text description for this image

Similar pages

Browse jobs